Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290706
Status:
TERMINATED
Last Update Posted:
2019-05-28
First Post:
2006-02-09
Brief Title:
A Phase III Trial of VELCADE Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkins Lymphoma
Sponsor:
Northwestern University
Organization:
Northwestern University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2011-02-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-09
First Submit QC Date:
February 9 2006
Study First Post Date:
2006-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-05-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-24
Last Update Post Date:
2019-05-28
Last Update Post Date Type:
ACTUAL